000 01273 a2200325 4500
005 20250517011604.0
264 0 _c20150708
008 201507s 0 0 eng d
022 _a1945-7197
024 7 _a10.1210/jc.2014-3963
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHallen, André
245 0 0 _aLetter to the editor: μ-crystallin/CRYM functions as a ketimine-reducing enzyme and plays a role in thyroid hormone bioavailability due to strong inhibition/regulation by thyroid hormones.
_h[electronic resource]
260 _bThe Journal of clinical endocrinology and metabolism
_cJan 2015
300 _aL15-6 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAdipose Tissue
_xmetabolism
650 0 4 _aCrystallins
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInsulin Resistance
_xphysiology
650 0 4 _aMale
650 0 4 _aObesity, Morbid
_xmetabolism
650 0 4 _aThyroid Gland
_xphysiopathology
650 0 4 _aThyroid Hormones
_xmetabolism
650 0 4 _amu-Crystallins
700 1 _aCooper, Arthur J L
773 0 _tThe Journal of clinical endocrinology and metabolism
_gvol. 100
_gno. 1
_gp. L15-6
856 4 0 _uhttps://doi.org/10.1210/jc.2014-3963
_zAvailable from publisher's website
999 _c24506324
_d24506324